Strativest CapitalSTRATIVEST RESEARCH
Independent research · Est. October 2026
← All X-Rays
Stock X-Ray · Industrials · S&P 500 Full Coverage — Phase 1

Paychex (PAYX)

X-Ray dated Oct 28, 2026 · Share price as of Oct 28, 2026 intraday, when the valuation snapshot was captured · Financials from SEC filings (EDGAR) · Valuation multiples from a labelled secondary source
The verdict — valuation label: FAIRLY PRICED

Forward P/E is 17.87x against a peer median of 19.61x, a ratio of 0.91x — inside the 0.90–1.15 fairly priced band — with trailing P/E 21.43x and PEG 2.29. The move to undervalued needs growth at or above the cluster median and a PEG at or below about 1.2; neither holds, so the label stays fairly priced. Latest-quarter revenue grew 5.9% year over year (PRIMARY, EDGAR). Delivered demand check: the Business services, data & distribution group's median growth was 7.2% year over year — demand steady, and this company is growing a little below that pace.

17.9×
Forward P/E — price vs next year’s expected earnings (secondary source)
19.6×
Peer median forward P/E — closest comparable companies
21.4×
Trailing P/E — price vs the last twelve months of earnings
5.9×
Price / sales

What would change this label: Move to UNDERVALUED if the forward P/E compresses to about 17.6x or below (0.90x the peer median) at unchanged estimates and the PEG falls to about 1.2 or below, with revenue growth rising to at least 7.2% year over year. Move to OVERVALUED if the forward P/E rises to about 22.6x or above (1.15x the peer median) at unchanged estimates, or if revenue growth falls below 3% year over year for two quarters.

In simple words

Paychex provides payroll and human-resources services to small and mid-sized businesses. Its shares cost slightly less than similar companies, while sales grew a modest 5.9%. That makes the shares look fairly priced — the small discount is not enough, on growth and the growth-adjusted measure, to call them undervalued.

Words we use, in plain English: P/E ratio — the share price divided by earnings per share; how many dollars you pay for one dollar of yearly profit. Forward P/E — the same, using next year’s expected earnings. Free cash flow — cash a company has left after running the business and buying equipment. TTM — the last twelve months. Drawdown — the worst fall from a peak to the low after it.
The share price vs the market — six years
Paychex (PAYX)S&P 500 (SPY)
811191561942312021202220232024202520262020-09-012026-10-27

Both lines start at 100 on 2020-09-01. Over the full window Paychex returned +43.27% and the S&P 500 +118.28% (price returns; dividends not reinvested). Worst peak-to-trough fall for Paychex: -46.5% (2025-06-06 to 2026-04-10). Source: Nasdaq official daily history.

What the label rests on

Forward P/E is 17.87x against a peer median of 19.61x, a ratio of 0.91x — inside the 0.90–1.15 fairly priced band — with trailing P/E 21.43x and PEG 2.29. The move to undervalued needs growth at or above the cluster median and a PEG at or below about 1.2; neither holds, so the label stays fairly priced. Latest-quarter revenue grew 5.9% year over year (PRIMARY, EDGAR). Delivered demand check: the Business services, data & distribution group's median growth was 7.2% year over year — demand steady, and this company is growing a little below that pace. The company’s forward P/E is 17.9× against a peer median of 19.6×. Its own history: UNVERIFIED — no sourced range available. Sector demand read: Delivered demand check: the Business services, data & distribution group's median latest-quarter revenue growth was 7.2% year over year (SEC filings) — demand steady, and this company is growing a little below that pace at 5.9%. Latest-quarter sales growth was +5.9% versus a year earlier (SEC filings).

CompanyPrice (Oct 28, 2026)Forward P/ETrailing P/E
Paychex (PAYX)$108.0517.9×21.4×
FERG—19.4×22.5×
VRSK—23.0×28.9×
EFX—19.6×28.7×
BR—16.8×18.5×
FAST—37.3×41.6×
Peer median19.6×

Multiples: stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026. Peer set chosen by sector; the median is the middle value of the set. The label and its numbers were recorded in the programme’s label registry on Oct 28, 2026 and will be scored at 6 and 12 months.

Sales, profit and cash

Sales and profit each quarter
SalesNet income (profit)
$0B$1B$1B$2BNov 2020Nov 2021Nov 2022Nov 2023Nov 2024Nov 2025Aug 2026

This company does not report a gross-profit line in its SEC facts (normal for banks, payment networks and some health insurers), so profit is shown as net income instead — gross margin is marked UNVERIFIED-absent rather than estimated.

Cash left over each quarter (free cash flow)
PositiveNegative
$-1B$0B$1BNov 2020Nov 2021Nov 2022Nov 2023Nov 2024Nov 2025Aug 2026

Free cash flow = cash from operations minus spending on plant and equipment, both from the company’s SEC cash-flow statement. Gaps are quarters where that spending line is not separately tagged in the filings — shown as gaps, never estimated.

QuarterSalesGross marginNet incomeEPS (GAAP, diluted)Free cash flow
Q/E Aug 2026
2026-08-31
$1.6B—$430M1.21$357M
Q/E May 2026
2026-05-31
$1.6B—$421M—$515M
Q/E Feb 2026
2026-02-28
$1.8B—$560M1.56$762M
Q/E Nov 2025
2025-11-30
$1.5B—$395M1.10$383M
Q/E Aug 2025
2025-08-31
$1.5B—$384M1.06$662M
Q/E May 2025
2025-05-31
$1.4B—$297M—$283M
Q/E Feb 2025
2025-02-28
$1.5B—$519M1.43$667M
Q/E Nov 2024
2024-11-30
$1.3B—$413M1.14$248M
Q/E Aug 2024
2024-08-31
$1.3B—$427M1.18$510M
Q/E May 2024
2024-05-31
$1.3B—$380M—$180M
Q/E Feb 2024
2024-02-29
$1.4B—$499M1.38$631M
Q/E Nov 2023
2023-11-30
$1.2B—$393M1.08$308M

The last twelve reported quarters. Full 24-quarter history sits in the data pack behind this page. A dash means the figure is not tagged as a standalone quarter in the company’s SEC facts (the usual case is the fourth quarter, which many companies only report inside the full-year filing) — it is missing, not zero.

Earnings: getting better or worse?

Each box is one quarter’s earnings per share (EPS). Green means EPS was higher than the same quarter a year earlier; red means lower; a dash means the figure is not tagged in the filings.

Nov 2022
0.99
Feb 2023
1.29
May 2023
—
Aug 2023
1.16
Nov 2023
1.08
Feb 2024
1.38
May 2024
—
Aug 2024
1.18
Nov 2024
1.14
Feb 2025
1.43
May 2025
—
Aug 2025
1.06
Nov 2025
1.10
Feb 2026
1.56
May 2026
—
Aug 2026
1.21

Basis: GAAP diluted EPS from SEC company facts, compared with the same quarter a year earlier.

Key facts

ItemValue
Company (legal name in filings)PAYCHEX INC
Chief executiveJohn Gibson (source: https://www.paychex.com/newsroom/news-releases/paychex-2026-worlds-most-ethical-companies)
SectorIndustrials — Human Resource & Employment Services — provides payroll and human-resources services to small and mid-sized businesses
Share price (Oct 28, 2026)$108.05
Market value (market cap)$38.9B — share price times shares outstanding of 355,980,473 (SEC filings; SEC EDGAR dei EntityCommonStockSharesOutstanding (latest))
Sales, last twelve months$6.4B
Net income, last twelve months$1.8B
Free cash flow, last twelve months$2.0B
Latest reported quarterQ/E Aug 2026 (of 24 quarters in the data pack)
Six-year price return vs S&P 500+43.27% vs +118.28%
Worst peak-to-trough fall-46.5% (2025-06-06 to 2026-04-10)

What we could not verify

  • Gross profit / gross margin: not tagged as a standalone line in this company's EDGAR company facts (common for banks, payment networks and some healthcare payers) — shown as UNVERIFIED-absent; the page charts revenue and net income instead.
  • TTM GAAP diluted EPS could not be summed from company facts because at least one of the last four quarters (typically Q4) has no standalone tagged EPS; trailing P/E is therefore taken from the labelled secondary source in valuation_label.md.
  • Own-history P/E (5-year median): not computed in the Phase 1 batch — UNVERIFIED
  • Guidance record (each quarter scored against the guidance the company gave the quarter before) is not yet compiled for this company — it is a Phase 2 layer. The earnings strip below therefore uses reported EPS versus a year earlier, which is fully sourced from filings.

The IT factor — the most exciting thing the market is overlooking — is not assessed on an X-Ray page. It belongs to the Deep Dive (Phase 2), where it gets the evidence standard it needs. Leadership-era scoring (the six years split by chief executive) is likewise a Phase 2 layer; this page names the current chief executive only, from a sourced profile.

Sources

  • SEC EDGAR submissions — Filing index; company legal name. https://data.sec.gov/submissions/CIK0000723531.json
  • SEC EDGAR company facts — Quarterly financial spine: revenue, gross profit, net income, GAAP diluted EPS, operating cash flow, PP&E capex, buybacks, dividends, diluted shares. https://data.sec.gov/api/xbrl/companyfacts/CIK0000723531.json
  • Nasdaq official daily history — Daily closes for the company; SPY (assetclass=etf) saved as raw/nasdaq_spy_raw.json over identical dates. https://api.nasdaq.com/api/quote/PAYX/historical?assetclass=stocks
  • Valuation multiples and peer figures — stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026; see valuation_label.md in the data pack.

Conventions: earliest-filed value per period, as first reported; cash-flow years-to-date differenced quarter by quarter; EPS never differenced; free cash flow = operating cash flow minus plant-and-equipment spending. This page is a dated snapshot — updates are new versions, never silent edits.

← All X-RaysS&P 500 Full Coverage — Phase 1 · Oct 28, 2026